Related Experiment Video
Updated: Mar 11, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Aortic Valve Calcium Score Spectrum Identifies Bimodal Outcomes for Transcatheter Aortic Valve Implantation: Insights
Yeela Talmor-Barkan1,2, Marco Barbanti3,4, Roberto Valvo4
1Department of Cardiology Rabin Medical Centre Petach-Tikva Israel.
Insights
Aortic stenosis severity varies. Low aortic valve calcium scores (AVCS) indicate fibrosis and worse outcomes, while very-high AVCS suggest higher procedural risks. Both extremes impact 3-year mortality.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Medical Imaging
Background:
- Degenerative calcification is the primary cause of severe aortic stenosis.
- Some patients with severe aortic stenosis have low aortic valve calcium scores (AVCS), indicating heterogeneous disease processes.
Purpose of the Study:
- To evaluate clinical characteristics and outcomes across the spectrum of aortic valve calcium scores (AVCS) in severe aortic stenosis patients.
Main Methods:
- Retrospective analysis of 3766 patients with severe aortic stenosis from the AMTRAC registry (2013-2024).
- Patients stratified into low, high, or very-high AVCS groups.
- Primary endpoint: 3-year mortality; Secondary endpoints: periprocedural outcomes and post-transcatheter aortic valve implantation hemodynamics.
Main Results:
- Low AVCS patients presented with low-gradient aortic stenosis and advanced symptoms.
- Mortality showed a bimodal pattern: 30.5% (low AVCS), 26.5% (high AVCS), 31.3% (very-high AVCS) at 3 years.
- Higher rates of moderate-to-severe paravalvular leak, stroke, and permanent pacemaker implantation were observed in very-high AVCS group.
Conclusions:
- Low AVCS signifies a unique phenotype of fibrosis, advanced symptoms, and increased mortality.
- Very-high AVCS is associated with greater procedural risks, bicuspid valves, and elevated mortality.
- Findings challenge calcification-based criteria and support integrating fibrosis assessment into treatment strategies for aortic stenosis.
Background:
Degenerative calcification is the primary mechanism underlying severe aortic stenosis; however, some patients with hemodynamically severe aortic stenosis have low aortic valve calcium scores (AVCS), suggesting heterogeneous disease processes. This study aimed to evaluate the clinical characteristics and outcomes across the spectrum of AVCS.
Methods:
We performed a retrospective analysis of the AMTRAC (Aortic+Mitral Transcatheter Valve) registry, including 3766 patients with severe aortic stenosis who underwent transcatheter aortic valve implantation across 16 centers mainly in Europe (2013-2024). Patients were stratified into three groups of low, high, or very high based on their AVCS. The primary end point was 3-year mortality. Secondary end points included periprocedural outcomes (Valve Academic Research Consortium-3) and posttranscatheter aortic valve implantation hemodynamics.
Results:
Patients with low AVCS more frequently presented with low-gradient aortic stenosis and advanced New York Heart Association classes. At 3 years, mortality displayed a bimodal pattern in association with AVCS spectrum: 30.5% in the low, 26.5% in the high, and 31.3% in the very-high AVCS group (P<0.05). Paravalvular leak greater than moderate increased with AVCS severity (0.5%, 0.9%, 1.9%, for low, high, and very-high AVCS, respectively; P<0.01). The risk for stroke and permanent pacemaker implantation were also higher in the very-high AVCS group compared with the low/high AVCS groups (stroke: 4.1%, 1.4%, 2.4%; permanent pacemaker: 21.2%, 14.7%, 14.2%; for very-high, low, high, respectively; P<0.05 for both).
Conclusions:
Low AVCS defines a unique phenotype marked by predominant fibrosis, advanced symptoms, and increased mortality despite fewer procedural complications. In contrast, very-high AVCS is linked to higher procedural risk, more bicuspid valves, and increased mortality. These insights challenge calcification-based criteria and support incorporating fibrosis assessment into treatment strategies.
More Related Videos
09:57Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
Published on: January 20, 2022
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Aortic Regurgitation I: Introduction
Mitral Valve Prolapse II: Assessment and Management